|
NCT06976034
|
oCular Examination at Cell RESolution With Optical TransmissionTomography (CERES-OTT)
|
En recrutement
|
18 mai 2025
|
|
NCT06248619
|
A Phase 3, Randomized, Double-masked, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous Teprotumumab in Participants With Moderate-to-Severe Active Thyroid Eye Disease
|
En recrutement
|
05 avril 2025
|
|
NCT06176352
|
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia (POYANG)
|
En recrutement
|
18 janvier 2025
|
|
NCT06307626
|
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Thyroid Eye Disease (UplighTED)
|
En recrutement
|
11 décembre 2024
|
|
NCT06450470
|
Multicenter, Randomized Study Evaluating the Use of a Non-sutured Sterile Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus
|
En recrutement
|
15 novembre 2024
|
|
NCT05748873
|
A Phase I/II Study to Assess the Safety and Tolerability of a Single Subretinal Administration of SPVN06 Gene Therapy in Subjects with Rod-Cone Dystrophy (RCD) Due to a Mutation in the RHO, PDE6A, or PDE6B Gene (PRODYGY)
|
En recrutement
|
20 septembre 2024
|
|
NCT05589714
|
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants (Uni-Rare)
|
En recrutement
|
17 juillet 2024
|
|
NCT04620876
|
Bimodal and Coaxial High Resolution Ophtalmic Imaging (AOSLO-OCT)
|
Statut inconnu
|
15 juin 2024
|
|
NCT04665726
|
Natural History Study of Usher Syndrome in a Cohort of Patients Followed Longitudinally for 5 Years (Light4Deaf)
|
En recrutement
|
15 juin 2024
|
|
NCT04639635
|
Study of CNGB1 Retinitis Pigmentosa and Allied Hereditary Disorders
|
En recrutement
|
15 juin 2024
|
|
NCT05957276
|
Global Patient Registry of Inherited Retinal Disease (EYERD Registry)
|
En recrutement
|
01 février 2024
|
|
NCT01954953
|
European Research Projects on Rare Diseases Driven by Young Investigators (EURUSH)
|
Statut inconnu
|
31 janvier 2024
|
|
NCT02377271
|
Effect of Bosentan in Patients With Non Arteritic Ischemic Optic Neuropathy (ENDOTHELION)
|
En recrutement
|
31 janvier 2024
|
|
NCT03614481
|
Clinical and Genetic Analyzes of Age-related Macular Degeneration (COLDMLA)
|
En recrutement
|
31 janvier 2024
|
|
NCT02957760
|
Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment. (PNPRO_HC)
|
Statut inconnu
|
31 janvier 2024
|
|
NCT04239196
|
Open Label Phase II Randomized Non-comparative Study of SC Tocilizumab Associated With IV Pulse Steroid Versus IV Pulse Steroid Alone for the Treatment of Acute Anterior Ischemic Optic Neuropathy Associated With Giant Cell Arteritis (TOCIAION)
|
En recrutement
|
31 janvier 2024
|
|
NCT04129021
|
High Resolution and High Speed Multimodal Ophthalmic Imaging (IMA-MODE)
|
En recrutement
|
31 janvier 2024
|
|
NCT04128150
|
High Resolution Retina Imaging (IHR)
|
Statut inconnu
|
31 janvier 2024
|
|
NCT04042363
|
Effect of Transorbital Electrical STIMulation of Optic Nerve on Remyelination After an Acute Optic Neuritis (ONSTIM)
|
Statut inconnu
|
31 janvier 2024
|
|
NCT04419285
|
Design of a Mobility Protocol to Assess the Impact of Visual Pathologies in Daily Life Activities for Subjects With Advanced Visual Deficits (PROMA)
|
Statut inconnu
|
31 janvier 2024
|
|
NCT03326336
|
A Phase 1/2a, Open-Label, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa (PIONEER)
|
En recrutement
|
31 janvier 2024
|